Form 4: Orthofix Medical Inc. Executive Acquires Shares and Stock Options
SEC Form 4 Filing
Jorge Andres Cedron, CLO of Orthofix Medical Inc., reports acquisition of common stock and stock options.
Summary
- On April 15, 2024, Jorge Andres Cedron, the Chief Legal Officer of Orthofix Medical Inc., acquired 28,648 shares of common stock at a price of $13.09 per share.
- Cedron also acquired 64,817 employee stock options with an exercise price of $13.09, expiring on April 15, 2031.
- The restricted stock units vest in three equal installments on the first, second, and third anniversaries of the grant date.
- The options vest in installments over three years from the grant date.
Sentiment
Score: 6
Explanation: Neutral sentiment as it's a standard disclosure of stock and option acquisition by an executive. It doesn't inherently indicate positive or negative performance, but rather transparency.
Positives
- The acquisition of shares and stock options by a company executive can be seen as a positive sign, indicating confidence in the company's future prospects.
Industry Context
This is a standard SEC Form 4 filing, reflecting changes in beneficial ownership by a company insider. Such filings are common and provide transparency to the market regarding insider transactions.
Key Dates
| Date | Description |
|---|---|
| 04/15/2024 | Date of transaction: acquisition of common stock and stock options |
| 04/15/2031 | Expiration date of the employee stock options |
| 04/17/2024 | Date of signature |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.